Peer-reviewedCC BYCureus
Comparative Evaluation of Concurrent Carboplatin-Paclitaxel Versus Cisplatin-Etoposide Chemoradiotherapy in Unresectable Non-small Cell Lung Cancer: A Prospective Randomized Study
- 1Radiation Oncology, Sri Venkateswara Institute of Medical Sciences (SVIMS), Tirupati, IND
Related
- Benmelstobart With or Without Anlotinib After Chemoradiotherapy for Unresectable Non−Small Cell Lung Cancer
- Durvalumab completion and re-administration after grade 2 radiation pneumonitis following concurrent chemoradiotherapy for unresectable stage III NSCLC: a single-center real-world study
- Evaluation of the Efficacy and Safety of Combination Therapy of Vamha and Myrha in the Management of PMOS: An Open-Label, Randomized, Multicentre, Comparative, Prospective Clinical Study
- Long-term survival patterns and prognostic stratification in patients with unresectable locally advanced squamous cell lung cancer receiving definitive chemoradiotherapy: a 14-year single-center real-world cohort.
- Comparative Evaluation of Postoperative Corneal Astigmatic Correction Following Pterygium Excision by Bare Sclera Technique Versus Conjunctival Limbal Autograft: A Prospective Observational Study
BibTeX
@article{kumar2026comparative,
title = {{Comparative Evaluation of Concurrent Carboplatin-Paclitaxel Versus Cisplatin-Etoposide Chemoradiotherapy in Unresectable Non-small Cell Lung Cancer: A Prospective Randomized Study}},
author = {Yamini Kumar and Bala Venkat Subramanian and G V Deepthi and Pranabandhu Das and Sreenivasa Rao Bonala},
journal = {Cureus},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13653729},
note = {CC BY},
}
RIS
TY - JOUR
TI - Comparative Evaluation of Concurrent Carboplatin-Paclitaxel Versus Cisplatin-Etoposide Chemoradiotherapy in Unresectable Non-small Cell Lung Cancer: A Prospective Randomized Study
AU - Yamini Kumar
AU - Bala Venkat Subramanian
AU - G V Deepthi
AU - Pranabandhu Das
AU - Sreenivasa Rao Bonala
PY - 2026
DA - 2026/10/16
JO - Cureus
UR - https://europepmc.org/article/PMC/PMC13653729
SN - 2168-8184
ER -